Major market players operating in the cancer registry software market include :
Elekta
C/NET Solutions
Electronic Registry Systems Inc.
Onco Inc.
McKesson Corporation
Siemens Healthineers
IBM Corporation
Ordinal data, Inc.
Conduent, Inc.
NeuralFrame, Inc
Authors:
Mariam Faizullabhoy, Gauri Wani
Frequently Asked Questions (FAQ) :
Global market size for cancer registry software was worth USD 71.4 million in 2022 and is poised to exhibit 10.5% CAGR to reach USD 193.4 million by 2032, driven by the rising prevalence of cancer.
The cancer registry software industry from the standalone software segment will expand at 10% CAGR to reach USD 143.7 million by 2032, attributed to the remarkable attributes of standalone software, including cost-effectiveness, flexibility, and ability to provide easy integration and data security.
Government organizations & third-party administration could witness 10% CAGR and dominate the end-use spectrum of the cancer registry software market due to increased investments and initiatives by these organizations in this space.
North America cancer registry software industry captured 51.6% market share in 2022, owing to the robust healthcare infrastructure and growing number of cancer cases in the region.